StockWatch
·

Welspun Corp Limited Q2 FY27 Results

WELCORPQ2 FY27 Results
Filing
Result:Good· Market: Down#Margin expansion#Cost led

Beat/Miss: Beat

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue4.6K13.8%6.2%
Total Income4.7K13.4%6.6%
Expenditure4.1K14.8%4.3%
PBT613.674.7%24.6%
Net Profit495.0952.8%11.6%
OPM15.65%1.31pp2.13pp
NPM10.54%14.74pp0.48pp
EPS18.9152.3%13.2%
View full financials

Revenue growth was modest (+6.2%, below preview) but PAT (+11.6%) and EBITDA beat comfortably on genuine margin expansion (OPM 15.65% vs 13.52%) rather than one-offs, making this a healthy but not standout quarter.

Q2 FY-2027 RESULTS · WELCORP

Welspun Corp Q2 FY27: Consol PAT +12% YoY to ₹495 Cr on Margin Gains, Revenue +6%

PAT +11.63% YoY · revenue +6.18% · margins expanding · beat vs street

29 Oct 2026 · 3 min read
Revenue

₹4,643.72 Cr

+6.18% YoY

PAT (consolidated)

₹495.09 Cr

+11.63% YoY

Net margin

10.54%

+0.5pp YoY

EPS

₹18.91

Welspun Corp's consolidated PAT rose 11.6% YoY to ₹495.09 Cr (owners' share ₹498.56 Cr) on revenue of ₹4,643.72 Cr, up 6.2% YoY — a print that tracks almost exactly with the company's own board-meeting framing of "PAT +12% YoY on margin gains; revenue up 6%." Against our pre-result preview (Q2 revenue ~₹5,000 Cr, EBITDA ₹700-750 Cr, PAT ₹250-350 Cr), revenue came in roughly 7% light, but EBITDA (~₹802 Cr, 17.28% OPM) and PAT both beat the top of the expected range comfortably — profitability, not topline, is the story this quarter.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹4,643.72 Cr+13.8%+6.2%
Expenses₹4,084.88 Cr+14.8%+4.3%
PAT₹495.09 Cr-52.75%+11.63%
Net margin10.54%-14.7pp+0.5pp
EPS₹18.91-52.3%+13.2%

Margin expansion was the real driver: operating EBITDA margin rose to 17.28% from 16.05% a year ago, and net margin to 10.66% from 10.14%, helped by a better cost-of-materials ratio (62.7% of revenue vs 63.3% YoY) even as depreciation (+54% YoY, capex-led) and other expenses rose sharply on a widened consolidation base (WCPGL stake increased to 73.9%, Sintex entities, new JVs). Sequentially PAT looks down 52.7% QoQ (₹495.09 Cr vs ₹1,047.88 Cr), but that comparison is misleading: Q1 FY27 PAT included a ₹547.93 Cr one-off gain on the sale of EPIC shares; stripped of that, Q1's adjusted PAT was ~₹499.95 Cr, making Q2 essentially flat QoQ on a like-for-like basis, with OPM easing from Q1's 19.73%.

₹
1,450.741,835.822,220.92,605.982,991.062,52907-2708-1809-0910-0510-2810-29Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹2,529, down 7.7% over the past month of trading.

₹ Cr
0391.21782.421,173.63349.16Q1 FY26rev ₹3,551 Cr443.51Q2 FY26rev ₹4,374 Cr456.36Q3 FY26rev ₹4,532 Cr371.46Q4 FY26rev ₹4,313 Cr1,047.88Q1 FY27rev ₹4,081 Cr495.09Q2 FY27rev ₹4,644 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 6 quarters; revenue is at a 6-quarter high.

What management guided (1 FY-2027 call)
FY27 revenue target ₹20,000 Cr maintained (not increased). EBITDA target ₹2,850 Cr on track. Capex for KSA and US projects to be completed by FY27 year-end, full impact in FY28. FY29 early-stage discussions ongoing, no orders booked yet.

— This quarter: met

The standalone (parent-only) print tells a weaker story — PAT fell to ₹141.83 Cr from ₹365.75 Cr a year ago, but that prior-year quarter carried a ₹163.49 Cr exceptional gain; even adjusting for it, standalone PBT fell from ₹281.82 Cr to ₹186.00 Cr. This >3% divergence from the consolidated growth story reflects that subsidiary and JV contributions (Sintex, US/KSA pipe units, the EPIC associate) are now driving group profitability more than the parent entity alone. At the segment level, Steel held PBT near flat (₹571.64 Cr vs ₹552.81 Cr YoY) while the Others (plastics, including Sintex) segment's operating loss widened to ₹43.51 Cr from ₹28.29 Cr, a growing drag management will need to address.

  • W1

    Can OPM hold near 17%+ as H2 volumes ramp, given it already eased from Q1's (one-off-inflated) 19.73% to 17.28%?

  • W2

    FY27 guidance (₹20,000 Cr revenue / ₹2,850 Cr EBITDA) implies ~₹11,275 Cr of H2 revenue vs ₹8,725 Cr in H1 — watch Q3/Q4 execution on the record order book and new US/Jordan capacity (US expansion due March 2028, full P&L impact from FY28).

  • W3

    Others/plastics segment loss widened to ₹43.51 Cr this quarter — watch whether Sintex-related units narrow losses or keep dragging consolidated margins.

Clean typed statement, both schedules extracted; consol PBT bridges via PBT-before-JV (613.67) + share of JV/associate profit (41.91), no exceptional-items line used at consol level in any period. Consol Q1 FY27 PAT included a one-off ₹547.93 Cr gain on sale of EPIC shares (Note 4) not present in Q2 FY27 or Q2 FY26, so YoY is clean but QoQ is distorted. Standalone Q2 FY26 included a ₹163.49 Cr exceptional gain (NSPL stake sale), inflating that base. NCI took -₹3.47 Cr of Q2 FY27 consol PAT (owners' share ₹498.56 Cr).

Informational and educational content only. Not investment advice.